Literature DB >> 10196298

Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures.

H Asada1, V Klaus-Kovtun, H Golding, S I Katz, A Blauvelt.   

Abstract

Human herpesvirus 6 (HHV-6) has been implicated as a cofactor in the progressive loss of CD4(+) T cells observed in AIDS patients. Because dendritic cells (DC) play an important role in the immunopathogenesis of human immunodeficiency virus (HIV) disease, we studied the infection of DC by HHV-6 and coinfection of DC by HHV-6 and HIV. Purified immature DC (derived from adherent peripheral blood mononuclear cells in the presence of granulocyte-macrophage colony-stimulating factor and interleukin-4) could be infected with HHV-6, as determined by PCR analyses, intracellular monoclonal antibody staining, and presence of virus in culture supernatants. However, HHV-6-infected DC demonstrated neither cytopathic changes nor functional defects. Interestingly, HHV-6 markedly suppressed HIV replication and syncytium formation in coinfected DC cultures. This HHV-6-mediated anti-HIV effect was DC specific, occurred when HHV-6 was added either before or after HIV, and was not due to decreased surface expression or function of CD4, CXCR4, or CCR5. Conversely, HIV had no demonstrable effect on HHV-6 replication. These findings suggest that HHV-6 may protect DC from HIV-induced cytopathicity in AIDS patients. We also demonstrate that interactions between HIV and herpesviruses are complex and that the observable outcome of dual infection is dependent on the target cell type.

Entities:  

Mesh:

Year:  1999        PMID: 10196298      PMCID: PMC104181     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases.

Authors:  M Luppi; P Barozzi; R Garber; A Maiorana; G Bonacorsi; T Artusi; R Trovato; R Marasca; G Torelli
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

2.  Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

Authors:  P Lusso; B Ensoli; P D Markham; D V Ablashi; S Z Salahuddin; E Tschachler; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

3.  Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture.

Authors:  J A Levy; A Landay; E T Lennette
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

4.  Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6.

Authors:  D R Carrigan; K K Knox; M A Tapper
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

5.  Analysis of a glycoprotein of human herpesvirus 6 (HHV-6) using monoclonal antibodies.

Authors:  T Okuno; H Sao; H Asada; K Shiraki; M Takahashi; K Yamanishi
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

6.  Seroepidemiology of human herpesvirus 6 infection in normal children and adults.

Authors:  T Okuno; K Takahashi; K Balachandra; K Shiraki; K Yamanishi; M Takahashi; K Baba
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

7.  Dendritic cell infection, depletion and dysfunction in HIV-infected individuals.

Authors:  S E Macatonia; R Lau; S Patterson; A J Pinching; S C Knight
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

8.  HHV-6 infection in HIV-infected asymptomatic and AIDS patients.

Authors:  D V Ablashi; S Marsh; M Kaplan; J E Whitman; G R Pearson
Journal:  Intervirology       Date:  1998       Impact factor: 1.763

9.  Human herpes virus type 6 (HHV-6) and its in vitro effect on human immunodeficiency virus (HIV).

Authors:  G R Pietroboni; G B Harnett; T J Farr; M R Bucens
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

10.  Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population.

Authors:  J A Levy; F Ferro; D Greenspan; E T Lennette
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

View more
  12 in total

1.  Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation.

Authors:  L A Pinto; V Blazevic; B K Patterson; C Mac Trubey; M J Dolan; G M Shearer
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 2.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host.

Authors:  A Abendroth; G Morrow; A L Cunningham; B Slobedman
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 4.  CXCR4: a virus's best friend?

Authors:  Kathleen L Arnolds; Juliet V Spencer
Journal:  Infect Genet Evol       Date:  2014-05-02       Impact factor: 3.342

Review 5.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Authors:  Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita; Masaki Yasukawa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Authors:  Ronen Borenstein; Oded Singer; Adi Moseri; Niza Frenkel
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 8.  Immunological and regulatory functions of uninfected and virus infected immature and mature subtypes of dendritic cells--a review.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

9.  Novel gene therapy viral vector using non-oncogenic lymphotropic herpesvirus.

Authors:  Akihiro Shimizu; Nobuyuki Kobayashi; Kazuya Shimada; Kuniaki Oura; Tadao Tanaka; Aikou Okamoto; Kazuhiro Kondo
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

10.  Human herpesvirus 6A partially suppresses functional properties of DC without viral replication.

Authors:  Rasmus K L Gustafsson; Elin E Engdahl; Oscar Hammarfjord; Sanjaya B Adikari; Magda Lourda; Jonas Klingström; Mattias Svensson; Anna Fogdell-Hahn
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.